TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

11119	Companies
244817	Keywords
172888	Articles
132001	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 11/27/2025 at 00:15, 10 months 7 days ago

Transgene annonce la reprise de la cotation de ses actions sur Euronext Paris à compter de l’ouverture des marchés
Transgene annonce la reprise de la cotation sur Euronext Paris suite à l'augmentation de capital. Cordons : biotechnologie, immunothérapie, cancer, Euronext Paris, augmentation de capital

Euronext Paris Biotechnologie Augmentation De Capital Immunothérapie Cancer
BRIEF

published on 11/26/2025 at 23:37, 10 months 8 days ago

Transgene lève 105 millions d'euros pour le développement d'un vaccin contre le cancer

Biotechnologie Collecte De Fonds Vaccins Contre Le Cancer Transgene Plateforme Myvac®
BRIEF

published on 11/26/2025 at 23:37, 10 months 8 days ago

Transgene Raises €105 Million for Cancer Vaccine Development

Biotechnology Fundraising Cancer Vaccines Transgene Myvac® Platform
PRESS RELEASE

published on 11/26/2025 at 23:32, 10 months 8 days ago

Transgene Successfully Completes a Fundraising of c. €105 Million
Transgene successfully completes a fundraising of c. €105 million, enabling acceleration of myvac® program development and extending financial visibility until early 2028

Fundraising Cancer Vaccines Transgene Financial Visibility Myvac® Program
PRESS RELEASE

published on 11/26/2025 at 23:32, 10 months 8 days ago

Transgene réalise avec succès une levée de fonds d’environ 105 millions d’euros
Transgene réalise avec succès une levée de fonds d'environ 105 millions d’euros pour accélérer le développement de son programme myvac® de vaccins thérapeutiques individualisés contre le cancer

Levée De Fonds Cancer Transgene Vaccins Thérapeutiques Myvac®
BRIEF

published on 11/25/2025 at 22:06, 10 months 9 days ago

Transgene lève des fonds avec le projet Talisman

Euronext Paris Levée De Fonds Transgene Talisman Myvac®
BRIEF

published on 11/25/2025 at 22:06, 10 months 9 days ago

Transgene raises funds with the Talisman project

Euronext Paris Fundraising Transgene Talisman Myvac®
PRESS RELEASE

published on 11/25/2025 at 22:01, 10 months 9 days ago

DOCUMENT D'INFORMATION ETABLI CONFORMEMENT À L'ANNEXE IX DU REGLEMENT (UE) 2017/1129 DU PARLEMENT EUROPEEN ET DU CONSEIL DU 14 JUIN 2017, TEL QUE MODIFIE
Transgene SA émet des actions nouvelles dans le cadre d'une augmentation de capital conformément au Règlement Prospectus. Montant brut total de l'émission: 105 millions d'euros. Prix d'émission maximum: 1,36 euro.

Euronext Paris Augmentation De Capital Actions Nouvelles TRANSGENE SA Règlement Prospectus
BRIEF

published on 11/25/2025 at 21:47, 10 months 9 days ago

Suspension temporaire de la cotation des actions Transgene

Euronext Paris Biotechnologie Augmentation De Capital Cotation Transgene
BRIEF

published on 11/25/2025 at 21:47, 10 months 9 days ago

Temporary suspension of trading in Transgene shares

Euronext Paris Biotechnology Capital Increase Transgene Quoting

Accesswire

Published on 10/03/2026 at 02:35, 1 day 21 hours ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 2 days 6 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 2 days 10 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 10 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 10 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/04/2026 at 06:05, 17 hours 51 minutes ago

Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 18 hours 41 minutes ago

SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 8 hours ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 2 days ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 2 days 3 hours ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding

Les Echos

Published on 10/02/2026 at 17:45, 2 days 6 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 6 hours ago

Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 6 hours ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 6 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 2 days 6 hours ago

Aéroports de Paris SA - Calendrier financier 2027

View all LES ECHOS COMFI WIRE